To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Impact
This bill will modify existing federal drug laws by creating clearer pathways for the approval and usage of drugs deemed as breakthrough therapies. This approach could facilitate faster access to medications that may be beneficial for serious or life-threatening conditions when no satisfactory alternatives exist. Supporters argue that this could significantly improve patient care and treatment outcomes, particularly for those suffering from severe illnesses. However, such modifications also come with the challenge of ensuring that proper safety and efficacy measures remain intact during the drug approval process.
Summary
House Bill 1393 aims to amend the Controlled Substances Act by defining 'currently accepted medical use with severe restrictions' for certain drugs and substances. The bill specifies that a drug or substance can be classified as having currently accepted medical use under strict conditions, particularly relating to its designation as a breakthrough therapy or its authorization for expanded access by the Secretary of Health and Human Services. These changes intend to streamline the classification of drugs that offer potential therapeutic benefits under specific regulatory frameworks.
Contention
Notably, opposition to the bill may arise from concerns about the broader implications of loosening restrictions on controlled substances. Critics might argue that, while aimed at improving patient access to potentially life-saving drugs, the changes could also lead to misuse or inappropriate distribution of substances that currently have strict regulations. There is a delicate balance between facilitating medical use and maintaining control over potentially harmful drugs, making this a point of contention in discussions surrounding HB 1393.
Controlled substances: other; definition of governmental agency under the administration of opioid antagonist act; modify. Amends sec. 101 of 2019 PA 39 (MCL 15.671). TIE BAR WITH: SB 404'25
Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition of fentanyl-related controlled substance in the criminal code.
Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
Adds certain psychoactive substances to the list of Schedule I controlled substances and modifies the offenses of possession of a controlled substance and delivery of a controlled substance
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.
Crimes: controlled substances; crime of manufacturing, delivering, or possession of with intent to deliver certain controlled substances; modify penalties. Amends secs. 7401, 7410 & 7417 of 1978 PA 368 (MCL 333.7401 et seq.) & adds secs. 7410b & 7417a.